Is This Stock a Screaming Buy: Surmodics, Inc. (NASDAQ:SRDX)

Equity Research firms currently have a positive stance on shares of Surmodics, Inc. (NASDAQ:SRDX). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.30. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $32.56 on a short term basis.

At the time of writing, the stock was trading at $29.00. This represents a change from the opening price of -1.26%. In terms of performance, year to date, the stock is 44.20%. The monthly stock performance comes in at -0.48%. For the quarter, shares are performing at 18.53%. Weekly performance analysis shows the equity at -0.20%.

In taking a look at technical levels, shares are trading 1.01% away from the 50 day simple moving average and 26.84% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -5.69% away from it’s 52- week high and 66.19% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Surmodics, Inc.’s RSI stands at 48.29. In looking at volatility levels, the shares saw weekly volatility of 3.65% and 3.08% over the past month.

Leave a Comment